In vitro activity of DNF-3 against drug-resistant Mycobacterium tuberculosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Islam, Md Imtiazul | - |
dc.contributor.author | Han, Choi Moon | - |
dc.contributor.author | Seo, Hoonhee | - |
dc.contributor.author | Kim, Sukyung | - |
dc.contributor.author | Al Mahmud, Hafij | - |
dc.contributor.author | Nam, Kung-Woo | - |
dc.contributor.author | Lee, Byung-Eui | - |
dc.contributor.author | Sadu, Venkata S. | - |
dc.contributor.author | Lee, Kee-In | - |
dc.contributor.author | Song, Ho-Yeon | - |
dc.date.accessioned | 2021-08-11T09:43:46Z | - |
dc.date.available | 2021-08-11T09:43:46Z | - |
dc.date.issued | 2019-07 | - |
dc.identifier.issn | 0924-8579 | - |
dc.identifier.issn | 1872-7913 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/4452 | - |
dc.description.abstract | Due to the emergence of multidrug-resistant and extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis, new antituberculosis drugs are urgently required to improve the efficacy of current tuberculosis (TB) treatment. To achieve this goal, ca. 1000 chemical compounds were screened for potential antimycobacterial activity, among which methyl 5-(2-diethylaminoethoxy)-7,12-dioxo-7,12 dihydrodinaphtho[1,2-b;2',3'-d]furan-6-carboxylate (DNF-3) showed strong activity against all of the tested drug-susceptible and -resistant M. tuberculosis strains, with 50% minimum inhibitory concentrations (MIC50 values) of 0.02-0.39 mu g/mL both in culture broth and within murine RAW 264.7 macrophage cells. When DNF-3 was used in combination with rifampicin or streptomycin, it exhibited direct synergy against XDR-TB and an additive effect against M. tuberculosis H37Rv. DNF-3 displayed a long post-antibiotic effect (PAE) that was comparable with rifampicin but was superior to isoniazid, streptomycin and ethambutol. Importantly, DNF-3 showed no cytotoxicity to any cell line tested, with a selectivity index (SI) of >32. DNF-3 was also active against 27 nontuberculous mycobacteria (NTM) strains, Staphylococcus spp. and Streptococcus spp. Taken together, these results indicate that DNF-3 is a promising new candidate drug for treating TB. Further studies are warranted to establish the in vivo effect and therapeutic potential of DNF-3. (C) 2019 Published by Elsevier B.V. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier BV | - |
dc.title | In vitro activity of DNF-3 against drug-resistant Mycobacterium tuberculosis | - |
dc.type | Article | - |
dc.publisher.location | 네델란드 | - |
dc.identifier.doi | 10.1016/j.ijantimicag.2019.02.013 | - |
dc.identifier.scopusid | 2-s2.0-85065831656 | - |
dc.identifier.wosid | 000470969800010 | - |
dc.identifier.bibliographicCitation | International Journal of Antimicrobial Agents, v.54, no.1, pp 69 - 74 | - |
dc.citation.title | International Journal of Antimicrobial Agents | - |
dc.citation.volume | 54 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 69 | - |
dc.citation.endPage | 74 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Microbiology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | MULTIDRUG-RESISTANT | - |
dc.subject.keywordPlus | DERIVATIVES | - |
dc.subject.keywordAuthor | DNF-3 | - |
dc.subject.keywordAuthor | Multidrug-resistant | - |
dc.subject.keywordAuthor | Extensively drug-resistant | - |
dc.subject.keywordAuthor | MDR/XDR-TB | - |
dc.subject.keywordAuthor | Mycobacterium tuberculosis | - |
dc.subject.keywordAuthor | NTM | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.